Rosemont Pharmaceuticals
Navdeep Kalsi has extensive experience in the pharmaceutical and healthcare sectors, with a career spanning over two decades. Currently serving as a Territory Manager at Rosemont Pharmaceuticals since March 2022, Kalsi previously held positions such as Account Manager at Graphite Digital and Medical Representative at Syneos Health. Prior roles include Account Manager at Ashfield, Network Sales Specialist at Pfizer, and Medical Representative positions with Apodi Limited, MSD, AstraZeneca, and Novartis. Kalsi's diverse background highlights a strong foundation in sales and account management within the industry.
Rosemont Pharmaceuticals
At Rosemont our mission is to be a rapid developer, reliable manufacturer and global supplier of novel-delivery, patient-focused medicines. Our ambition has always been to support both patients with swallowing difficulties and the healthcare professionals who care for them. We are highly respected in the industry and have been instrumental in establishing best practice for the care of patients with swallowing difficulties. Rosemont advocate the use of liquid medication over manipulating solid dose medications and we have a range of educational materials designed for healthcare professionals which focuses on key patient groups and their medication management challenges. At Rosemont we have a portfolio of over 130 oral liquid medicines across a range of therapeutic areas including 70 licensed products. All of our products, both licensed and ‘specials’ are made to the same exacting standards under GMP. Our UK range also includes 9 products licensed for use with PEG/NG tubes. We are always seeking to expand our range of medicines and covert our ‘specials’ to licensed product wherever possible.